SALVADOR CEVALLOS: Open Payments
NPI 1992926661 · SOUTH DAYTONA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$804 in 38 payments from 12 companies in 2025. Trend: 2023 $795 · 2024 $800 · 2025 $804
Food & beverage: $804
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 5 | $109 |
| Collegium Pharmaceutical, Inc. | 5 | $92 |
| Lundbeck LLC | 4 | $89 |
| Tris Pharma Inc | 4 | $88 |
| Supernus Pharmaceuticals, Inc. | 4 | $86 |
| Axsome Therapeutics, Inc. | 3 | $83 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $80 |
| Corium, LLC | 4 | $62 |
| Otsuka America Pharmaceutical, Inc. | 2 | $42 |
| Neurocrine BioSciences, Inc. | 2 | $37 |
Products named: REXULTI, VRAYLAR, Jornay PM, Qelbree, Auvelity, CAPLYTA, Onyda XR, Azstarys.
Industry payments across FL — which companies pay providers there.
